Understanding the Multiple Reasons Why Clemastine Fumarate Was Discontinued
•
4 min read
In 2005, the FDA formally withdrew its approval for the branded prescription Tavist (clemastine fumarate) 2.68 mg at the manufacturer’s request, stating the withdrawal was not for safety or effectiveness reasons. However, this is only one part of the complex story of **why was Clemastine fumarate discontinued**, with other factors influencing the fate of different clemastine products over time.
